Genomic Test Does Not Increase Active Surveillance Acceptance for Treating Favorable-Risk Prostate Cancer
The results from a trial evaluating the Genomic Prostate Score did not find an increase in active surveillance acceptance amongst... Read More
The results from a trial evaluating the Genomic Prostate Score did not find an increase in active surveillance acceptance amongst... Read More